School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai, 200433, China.
Department of Nephrology, Shanghai Changhai Hospital, Naval Medical University, No. 168 Changhai Road, Shanghai, 200433, China.
J Pharm Biomed Anal. 2021 Feb 20;195:113825. doi: 10.1016/j.jpba.2020.113825. Epub 2020 Dec 4.
Crystal-induced kidney injury (CIKI) is the fundamental pathological change during nephrolithiasis, although the molecular mechanism is still unclear. Pyrrosia calvata (Bak.) Ching has been used in folk medicine to treat urolithiasis for years. To clarify the pharmacodynamic substances and the mechanism of its antiurolithiasis effects, in this study, a novel, stop-flow, comprehensive, two-dimensional (2D) HK-2 and HK-2/CIKI cell membrane chromatography (CMC) comparative analysis system was developed to screen for the potential active ingredients from Pyrrosia calvata (Bak.) Ching against CIKI. The comprehensive 2D CMC comparative analysis system showed satisfactory selectivity, and eight ingredients were screened and identified by this system. Among them, mangiferin exhibited higher affinity for the HK-2/CIKI CMC column than the HK-2 CMC column and was selected for further efficacy verification. Cell proliferation assays showed that mangiferin could protect HK-2 cell viability after stimulation with sodium oxalate (NaOX). Additionally, in a rodent model of CIKI, mangiferin decreased the deposition of calcium oxalate (CaOX) crystals in mouse kidneys, alleviated the pathological damage to kidney tissue, and inhibited the upregulation of OPN, MCP1, and CD44 expression caused by CaOX crystals. The established comprehensive 2D CMC comparative analysis system can be applied to screen active ingredients with disease specificity from traditional Chinese medicine (TCM) and is suitable for other cell models.
晶体相关性肾损伤(CIKI)是肾结石形成过程中的基本病理变化,尽管其分子机制尚不清楚。庐山石韦(Bak.)Ching 多年来一直被民间用于治疗尿路结石。为了阐明其抗结石作用的药效物质基础和作用机制,本研究建立了一种新颖的、停流、全面的二维(2D)HK-2 和 HK-2/CIKI 细胞膜色谱(CMC)比较分析系统,用于筛选针对 CIKI 的庐山石韦潜在活性成分。该全面的 2D CMC 比较分析系统显示出良好的选择性,通过该系统筛选并鉴定了 8 种成分。其中,芒果苷对 HK-2/CIKI CMC 柱的亲和力高于 HK-2 CMC 柱,因此被选择用于进一步的疗效验证。细胞增殖实验表明,芒果苷可在草酸鈉(NaOX)刺激后保护 HK-2 细胞活力。此外,在 CIKI 啮齿动物模型中,芒果苷可减少小鼠肾脏中草酸钙(CaOX)晶体的沉积,减轻肾脏组织的病理损伤,并抑制 CaOX 晶体引起的 OPN、MCP1 和 CD44 表达上调。所建立的全面的 2D CMC 比较分析系统可用于从中药(TCM)中筛选具有疾病特异性的活性成分,也适用于其他细胞模型。